MARKET

AVR

AVR

ANTERIS TECHNOLOGIES GLOBAL
NASDAQ
4.670
+0.130
+2.86%
After Hours: 4.670 0 0.00% 17:01 12/05 EST
OPEN
4.540
PREV CLOSE
4.540
HIGH
4.775
LOW
4.540
VOLUME
81.05K
TURNOVER
--
52 WEEK HIGH
8.79
52 WEEK LOW
2.340
MARKET CAP
192.39M
P/E (TTM)
-1.9951
1D
5D
1M
3M
1Y
5Y
1D
Anteris Technologies Holds Annual Stockholders Meeting
TipRanks · 3d ago
ANTERIS TECHNOLOGIES GLOBAL CORP-ANNUAL MEETING CEO PRESENTATION
Reuters · 3d ago
Anteris Technologies Ends Agreement with 4C Medical
TipRanks · 5d ago
Anteris Technologies Declines Renewal Of ADAPT Tissue Supply Agreement With 4C Medical, Contract To End June 2026; Termination Does Not Impact Financial Results
Benzinga · 5d ago
ANTERIS TECHNOLOGIES GLOBAL CORP - TERMINATION DOES NOT IMPACT FINANCIAL RESULTS - SEC FILING
Reuters · 5d ago
Weekly Report: what happened at AVR last week (1124-1128)?
Weekly Report · 6d ago
Anteris Technologies Global To Offer Up To 9.1M Shares Of Common Stock By The Selling Stockholders
Benzinga · 11/26 21:40
ANTERIS TECHNOLOGIES GLOBAL CORP - TO OFFER UP TO 9.1 MLN SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING
Reuters · 11/26 21:37
More
About AVR
Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.

Webull offers Anteris Technologies Global Corp stock information, including NASDAQ: AVR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVR stock methods without spending real money on the virtual paper trading platform.